코로나바이러스(SARS-CoV-2)에 대한 구강 양치액의 효과: 주제 범위 문헌고찰

키워드

참고문헌 (40)

1. WHO, "WHO Coronavirus Disease(COVID-19)Dashboard", World Health Organization, ~ (2021)
2. Li Q, "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia", N Engl J Med, 382(13), pp.1199~1207 (2020)
3. WHO, "Transmission of SARS-CoV-2 : implications for infection prevention precautions" (2021), World Health Organization
4. Yoo JY, "Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti", BMC Public Health, 20(1), pp.1853~ (2020)
5. Fernandes LL, "Saliva in the Diagnosis of COVID-19: A Review and New Research Directions", J Dent Res, 99(13), pp.1435~1443 (2020)
6. Zhu J, "Viral dynamics of SARS-CoV-2 in saliva from infected patients", J Infect, 81(3), pp.48~50 (2020)[DOI]
7. CDC, "Guidance for Dental Settings", Centers for Disease Control and Prevention (2020)
8. ADA, "ADA COVID-19 Risk Management Guidance", Australian Dental Association, ~ (2020)
9. O'Donnell VB, "Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection", Function (Oxf), 1(1) (2020)
10. Retamal-Valdes B, "Effectiveness of a pre-procedural mouthwash in reducing bacteria in dental aerosols : randomized clinical trial", Braz Oral Res, 31, pp.e21~ (2017)
11. Feres M, "The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office", J Am Dent Assoc, 141(4), pp.415~422 (2010)
12. WHO, "Considerations for the provision of essential oral health services in the context of COVID-19 : Interim guidance" (2020), World health Organization
13. Tricco AC, "PRISMA Extension for Scoping Reviews(PRISMA-ScR) : Checklist and Explanation", Ann Intern Med, 169(7), pp.467~473 (2018)
14. Khalil H, "An Evidence-Based Approach to Scoping Reviews", Worldviews Evid Based Nurs, 13(2), pp.118~123 (2016)
15. Hassandarvish P, "In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2 : implications for dental practice", Br Dent J, 2020, pp.1~4 (2020)
16. Bidra AS, "Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses", J Prosthodont, 29(7), pp.599~603 (2020)
17. Bidra AS, "Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2)Using Povidone-Iodine Oral Antiseptic Rinse", J Prosthodont, 29(6), pp.529~533 (2020)
18. Anderson DE, "The Virus Causing COVID-19 Disease", Infect Dis Ther, 9(3), pp.669~675 (2020)
19. Jain A, Grover V, Singh C,, "Chlorhexidine : An effective anticovid mouth rinse", J Indian Soc Periodontol, 25(1), pp.86~88 (2021)
20. Koch-Heier J, "Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX(®)and BacterX(®)Pro", Microorganisms, 9(3) (2021)
21. Komine A, "Virucidal activity of oral care products against SARS-CoV-2 in vitro", J Oral Maxillofac Surg Med Pathol, 33(4), pp.475~477 (2021)
22. Seneviratne CJ, "Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva : randomized control trial in Singapore", Infection, 49(2), pp.305~311 (2021)
23. Davies K, Buczkowski H, Welch SR,, "Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes", J Gen Virol, 102(4) (2021)
24. Steinhauer K, "Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476", J Hosp Infect, 111, pp.180~183 (2021)
25. Eduardo FP, "Salivary SARS-CoV-2 load reduction with mouthwash use : A randomized pilot clinical trial", Heliyon, 7(6), pp.e07346~ (2021)
26. Huang YH, "Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients", J Med Virol, 93(7), pp.4370~4373 (2021)
27. Muñoz-Basagoiti J, "Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro", J Dent Res, pp.220345211029269~ (2021)
28. Gottsauner MJ, "A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2", Clin Oral Investig, 24(10), pp.3707~3713 (2020)
29. Kawana R, "Inactivation of human viruses by povidone-iodine in comparison with other antiseptics", Dermatology, 195(2), pp.29~35 (1997)
30. Wood A, "The action of three antiseptics", disinfectants against enveloped and non-enveloped viruses, 1998, pp.38(4), 283~295
31. Frank S, "Povidone-Iodine Use in Sinonasal and Oral Cavities : A Review of Safety in the COVID-19 Era", Ear Nose Throat J, 99(9), pp.586~593 (2020)
32. Eggers M, "In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle", Mouthwash Against Respiratory and Oral Tract Pathogens, 2018, pp.7(2), 249~259
33. 이재관, "화학요법제(chemotherapeutic agents)를 이용한 비외과적 치주치료", 대한치과의사협회지, 46(6), pp.370~376 (2008), 대한치과의사협회[DOI]
34. Addy M, "Oral hygiene products : potential for harm to oral and systemic health?", Periodontol 2000, 48, pp.54~65 (2008)
35. Horner C, "Reduced susceptibility to chlorhexidine in staphylococci : is it increasing and does it matter?", J Antimicrob Chemother, 67(11), pp.2547~2559 (2012)
36. Van Strydonck DA, "gingival inflammation and staining in gingivitis patients : a systematic review", J Clin Periodontol, 39(11), pp.1042~1055 (2012)
37. Bernstein D, "In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse", J Dent Res, 69(3), pp.874~876 (1990)
38. Rosling BG, "Microbiological and clinical effects of topical subgingival antimicrobial treatment on human periodontal disease", J Clin Periodontol, 10(5), pp.487~514 (1983)
39. Bauroth K, "The efficacy of an essential oil antiseptic mouthrinse vs. dental floss in controlling interproximal gingivitis: a comparative study", J Am Dent Assoc, 134(3), pp.359~365 (2003)
40. Baker N, "Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19", Pharm Res, 37(6), pp.104~ (2020)

관련 논문AI추천